Single and Multiple Ascending Doses of AZD1981 in Japan (JSAD/JMAD)

AstraZeneca logo

AstraZeneca

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Drug: Placebo
Drug: AZD1981

Study type

Interventional

Funder types

Industry

Identifiers

NCT00698282
D9831C00005

Details and patient eligibility

About

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Enrollment

47 patients

Sex

Male

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy Japanese and Caucasian males

Exclusion criteria

Other clinically relevant disease or disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

47 participants in 3 patient groups, including a placebo group

1
Experimental group
Treatment:
Drug: AZD1981
2
Experimental group
Treatment:
Drug: AZD1981
3
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems